{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:53:28Z","timestamp":1762300408096},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Thymoma is the most common primary tumor in the anterior mediastinum. The prognostic factors of patients with thymoma still need to be clarified. In this study, we aimed to investigate the prognostic factors of patients with thymoma who received radical resection and establish the nomogram to predict the prognosis of these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Patients who underwent radical resection for thymoma with complete follow-up data between 2005 and 2021 were enrolled. Their clinicopathological characteristics and treatment methods were retrospectively analyzed. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan\u2013Meier method and compared by the log-rank test. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify the independent prognostic factors. According to the results of the univariate analysis in the Cox regression model, the predictive nomograms were created.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 137 patients with thymoma were enrolled. With a median follow-up of 52\u00a0months, the 5-year and 10-year PFS rates were 79.5% and 68.1%, respectively. The 5-year and 10-year OS rates were 88.4% and 73.1%, respectively. Smoking status (<jats:italic>P<\/jats:italic>\u2009=\u20090.022) and tumor size (<jats:italic>P<\/jats:italic>\u2009=\u20090.039) were identified as independent prognostic factors for PFS. Multivariate analysis showed that a high level of neutrophils (<jats:italic>P<\/jats:italic>\u2009=\u20090.040) was independently associated with OS. The nomogram showed that the World Health Organization (WHO) histological classification contributed more to the risk of recurrence than other factors. Neutrophil count was the most important predictor of OS in patients with thymoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Smoking status and tumor size are risk factors for PFS in patients with thymoma. A high level of neutrophils is an independent prognostic factor for OS. The nomograms developed in this study accurately predict PFS and OS rates at 5 and 10\u00a0years in patients with thymoma based on individual characteristics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-023-03068-9","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:01:27Z","timestamp":1689040887000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic factors in patients with thymoma who underwent surgery"],"prefix":"10.1186","volume":"21","author":[{"given":"Yu-Gang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu-Yuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Hong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"issue":"1","key":"3068_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer. 2008;44(1):123\u201330.","journal-title":"Eur J Cancer"},{"issue":"15","key":"3068_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025331","volume":"100","author":"J Wu","year":"2021","unstructured":"Wu J, Wang Z, Jing C, Hu Y, Yang B, Hu Y. The incidence and prognosis of thymic squamous cell carcinoma: a Surveillance, Epidemiology, and End Results Program population-based study. Medicine (Baltimore). 2021;100(15): e25331.","journal-title":"Medicine (Baltimore)"},{"issue":"10 Suppl 4","key":"3068_CR3","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S260\u2013265.","journal-title":"J Thorac Oncol"},{"key":"3068_CR4","doi-asserted-by":"crossref","unstructured":"Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM, Stamnes S, Lechtholz-Zey E, Wightman SC, Detterbeck FC,\u00a0et al. A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020;160(1):306-314. e314.","DOI":"10.1016\/j.jtcvs.2019.11.052"},{"issue":"2","key":"3068_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1245\/s10434-015-4825-4","volume":"23","author":"H Fu","year":"2016","unstructured":"Fu H, Gu ZT, Fang WT, Fu JH, Shen Y, Han YT, Yu ZT, Li Y, Tan LJ, Pang LW, et al. Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the Chinese Alliance for Research of Thymoma Database. Ann Surg Oncol. 2016;23(2):619\u201325.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3068_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.athoracsur.2013.04.078","volume":"96","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao H, Hu D, Fan L, Shi J, Fang W. Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. Ann Thorac Surg. 2013;96(3):1019\u201324.","journal-title":"Ann Thorac Surg"},{"issue":"23","key":"3068_CR7","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1111\/1759-7714.14725","volume":"13","author":"AC Agrafiotis","year":"2022","unstructured":"Agrafiotis AC, Siozopoulou V, Hendriks JMH, Pauwels P, Koljenovic S, Van Schil PE. Prognostic factors and genetic markers in thymic epithelial tumors: a narrative review. Thorac Cancer. 2022;13(23):3242\u20139.","journal-title":"Thorac Cancer"},{"issue":"39","key":"3068_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030867","volume":"101","author":"J Li","year":"2022","unstructured":"Li J, Liu Y, Zhang X, Zheng X, Qi G. Prognostic factors for overall survival after surgical resection in patients with thymic epithelial tumors: a systematic review and meta-analysis. Medicine (Baltimore). 2022;101(39): e30867.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3068_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/1759-7714.13750","volume":"12","author":"M Knetki-Wroblewska","year":"2021","unstructured":"Knetki-Wroblewska M, Kowalski DM, Olszyna-Serementa M, Krzakowski M, Szolkowska M. Thymic epithelial tumors: do we know all the prognostic factors? Thorac Cancer. 2021;12(3):339\u201348.","journal-title":"Thorac Cancer"},{"issue":"27","key":"3068_CR10","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2217\/fon-2017-0236","volume":"13","author":"GL Banna","year":"2017","unstructured":"Banna GL, Sheel A, Sheel V, Bille A, Routledge T, Fernando S, Nair A, Lal R. Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression. Future Oncol. 2017;13(27):2429\u201339.","journal-title":"Future Oncol"},{"issue":"3","key":"3068_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-0030-1250657","volume":"59","author":"S Demirci","year":"2011","unstructured":"Demirci S, Turhan K, Ozsan N, Yalman D, Cakan A, Cok G, Cagirici U, Ozkok S. Prognostic factors for survival in patients with thymic epithelial tumors. Thorac Cardiovasc Surg. 2011;59(3):153\u20137.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"7 Suppl 3","key":"3068_CR12","doi-asserted-by":"publisher","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","volume":"6","author":"F Detterbeck","year":"2011","unstructured":"Detterbeck F, Youssef S, Ruffini E, Okumura M. A review of prognostic factors in thymic malignancies. J Thorac Oncol. 2011;6(7 Suppl 3):S1698\u20131704.","journal-title":"J Thorac Oncol"},{"key":"3068_CR13","doi-asserted-by":"crossref","unstructured":"Alkaaki A, Abo Al-Saud A, Di Lena E, Ramirez-GarciaLuna JL, Najmeh S, Spicer J, Ferri L, Mulder D, Sirois C, Cools-Lartigue J. Factors predicting recurrence in thymic epithelial neoplasms. Eur J Cardiothorac Surg. 2022;62(5):ezac274.","DOI":"10.1093\/ejcts\/ezac274"},{"issue":"2","key":"3068_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10985-015-9330-3","volume":"22","author":"G Heller","year":"2016","unstructured":"Heller G, Mo Q. Estimating the concordance probability in a survival analysis with a discrete number of risk groups. Lifetime Data Anal. 2016;22(2):263\u201379.","journal-title":"Lifetime Data Anal"},{"key":"3068_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","volume":"99","author":"M Scorsetti","year":"2016","unstructured":"Scorsetti M, Leo F, Trama A, D\u2019Angelillo R, Serpico D, Macerelli M, Zucali P, Gatta G, Garassino MC. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332\u201350.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3068_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canep.2019.06.008","volume":"61","author":"M Eriksson","year":"2019","unstructured":"Eriksson M, Kaerlev L, Johansen P, Afonso N, Ahrens W, Costa-Pereira A, Guenel P, Jockel KH, Gonzalez AL, Merletti F, et al. Tobacco smoking and alcohol consumption as risk factors for thymoma - a European case-control study. Cancer Epidemiol. 2019;61:133\u20138.","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"3068_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.athoracsur.2018.11.038","volume":"107","author":"M Yanagiya","year":"2019","unstructured":"Yanagiya M, Matsumoto J, Kawahara T, Yamaguchi H, Nagayama K, Anraku M, Sato M, Nakajima J. Influence of smoking and histologic subtype on developing extrathymic malignancy in thymoma patients. Ann Thorac Surg. 2019;107(5):1532\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"3068_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/JTO.0000000000000482","volume":"10","author":"AC Roden","year":"2015","unstructured":"Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Cassivi SD, Marks RS, Garces YI, Aubry MC. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications. J Thorac Oncol. 2015;10(4):691\u2013700.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3068_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/ejcts\/ezz001","volume":"56","author":"M Okumura","year":"2019","unstructured":"Okumura M, Yoshino I, Yano M, Watanabe SI, Tsuboi M, Yoshida K, Date H, Yokoi K, Nakajima J, Toyooka SI, et al. Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg. 2019;56(1):174\u201381.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"3068_CR20","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/ejcts\/ezw178","volume":"50","author":"T Fukui","year":"2016","unstructured":"Fukui T, Fukumoto K, Okasaka T, Kawaguchi K, Nakamura S, Hakiri S, Ozeki N, Hirakawa A, Tateyama H, Yokoi K. Prognostic impact of tumour size in completely resected thymic epithelial tumours. Eur J Cardiothorac Surg. 2016;50(6):1068\u201374.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3068_CR21","doi-asserted-by":"crossref","unstructured":"Tseng YC, Hsu HS, Lin YH, Tseng YH, Shu CW, Goan YG, Tseng CJ. Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM? Thorac Cancer. 2022; 13(3):346\u2013352.","DOI":"10.1111\/1759-7714.14255"},{"issue":"3","key":"3068_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22(3):173\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3068_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14(1):173.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3068_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-017-0707-7","volume":"16","author":"A Ocana","year":"2017","unstructured":"Ocana A, Nieto-Jimenez C, Pandiella A, Templeton AJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017;16(1):137.","journal-title":"Mol Cancer"},{"issue":"1","key":"3068_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","volume":"132","author":"A Meager","year":"2003","unstructured":"Meager A, Wadhwa M, Dilger P, Bird C, Thorpe R, Newsom-Davis J, Willcox N. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis. Clin Exp Immunol. 2003;132(1):128\u201336.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"3068_CR26","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1245\/s10434-020-08228-9","volume":"27","author":"S Okada","year":"2020","unstructured":"Okada S, Shimomura M, Tsunezuka H, Ishihara S, Ikebe S, Furuya T, Shimada J, Teramukai S, Inoue M. High neutrophil count as a negative prognostic factor for relapse in patients with thymic epithelial tumor. Ann Surg Oncol. 2020;27(7):2438\u201347.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3068_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","volume":"17","author":"A Marx","year":"2022","unstructured":"Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, et al. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022;17(2):200\u201313.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"3068_CR28","doi-asserted-by":"publisher","first-page":"901","DOI":"10.21037\/jtd.2016.03.53","volume":"8","author":"GD Lee","year":"2016","unstructured":"Lee GD, Kim HR, Choi SH, Kim YH, Kim DK, Park SI. Prognostic stratification of thymic epithelial tumors based on both Masaoka-Koga stage and WHO classification systems. J Thorac Dis. 2016;8(5):901\u201310.","journal-title":"J Thorac Dis"},{"key":"3068_CR29","doi-asserted-by":"crossref","unstructured":"Chiappetta M, Lococo F, Pogliani L, Sperduti I, Tabacco D, Bria E, D\u2019Argento E, Massaccesi M, Boldrini L, Meacci E, et al. Masaoka-Koga and TNM staging system in thymic epithelial tumors: prognostic comparison and the role of the number of involved structures. Cancers (Basel). 2021;13(21):5254.","DOI":"10.3390\/cancers13215254"},{"key":"3068_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.629993","volume":"27","author":"D Valdivia","year":"2021","unstructured":"Valdivia D, Cheufou D, Fels B, Puhlvers S, Mardanzai K, Zaatar M, Weinreich G, Taube C, Theegarten D, Stuschke M, et al. Potential prognostic value of preoperative leukocyte count, lactate dehydrogenase and C-reactive protein in thymic epithelial tumors. Pathol Oncol Res. 2021;27: 629993.","journal-title":"Pathol Oncol Res"},{"key":"3068_CR31","doi-asserted-by":"publisher","first-page":"1034472","DOI":"10.3389\/fnins.2022.1034472","volume":"16","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhou S, Yang S, Mofatteh M, Hu Y, Wei H, Lai Y, Zeng Z, Yang Y, Yu J, et al. Developing and predicting of early mortality after endovascular thrombectomy in patients with acute ischemic stroke. Front Neurosci. 2022;16:1034472.","journal-title":"Front Neurosci"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03068-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:02:23Z","timestamp":1689040943000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03068-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"14 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethics Committee of the General Hospital of Ningxia Medical University (KYLL-2022\u20130013). Patient consent was waived due to the retrospective study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}